Imuran Related Published Studies
Well-designed clinical trials related to Imuran (Azathioprine)
Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. [2008.10]
Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse. [2008.09.04]
A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease. [2008.09]
A Multicenter, Randomized, Double-Blind Trial of Everolimus Versus Azathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's Disease. [2008.07.30]
Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation. [2007.12]
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. [2007.12]
Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis. [2007.12]
Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial. [2007.08]
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial. [2007.07]
Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience. [2007.06]
Mycophenolate Mofetil versus Azathioprine for Prevention of Chronic Allograft Dysfunction in Renal Transplantation: The MYSS Follow-Up Randomized, Controlled Clinical Trial. [2007.06]
A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. [2007.05]
Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data. [2007.03.15]
Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis. [2007.03]
Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. [2007.02]
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. [2006.12]
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. [2006.11]
Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients. [2006.10]
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. [2006.09]
Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. [2006.08.27]
Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. [2006.08]
Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. [2006.04.15]
Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial. [2006.04]
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. [2006.03.11]
A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis. [2006.03]
Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial. [2006.01]
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. [2006.01]
The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients. [2006]
Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study. [2005.12]
A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. [2005.06]
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. [2005.05]
Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study. [2005.03]
Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression. [2005.03]
Thiopurine methyltransferase enzyme activity determination before treatment of inflammatory bowel disease with azathioprine: effect on cost and adverse events. [2005.03]
Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation. [2005.02]
Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide. [2005]
Well-designed clinical trials possibly related to Imuran (Azathioprine)
A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas. [2008.10]
Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials. [2008.08]
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. [2008.06]
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study. [2008.04]
Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation. [2008.03]
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. [2008.02.23]
Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. [2008.02]
Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials. [2008.01.10]
Improving therapeutic options for patients with giant cell arteritis. [2008.01]
Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection. [2008.01]
Safety and efficacy of high dose ATG bolus administration on rewascularization in kidney graft patients - long term results. [2008]
A Lower Incidence of Cytomegalovirus Infection in De Novo Heart Transplant Recipients Randomized to Everolimus. [2007.12.15]
Successful Treatment of Steroid Refractory Active Ulcerative Colitis with Natural Interferon-beta - an Open Long-Term Trial. [2007.12]
A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. [2007.10]
Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. [2007.10]
Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression. [2007.09.27]
The effect of sirolimus therapy on vaccine responses in transplant recipients. [2007.08]
Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation. [2007.07]
Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. [2007.06.12]
Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis. [2007.06]
Exploratory calcineurin inhibitor-free regimens in living-related kidney transplant recipients. [2007.04]
Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer? [2007.03]
Topical tacrolimus in the treatment of perianal Crohn's disease: Exploratory randomized controlled trial. [2007.03]
Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study. [2007.02]
Therapy for children with henoch-schonlein purpura nephritis: a systematic review. [2007.01.10]
Vascular remodeling 1 year after cardiac transplantation. [2007.01]
Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS). [2007]
Medical therapy for Crohn's disease: top-down or step-up? [2007]
Immunoglobulin induction therapy in renal transplant recipients: Effects on immunoglobulin and regulatory antibody levels. [2006.12]
Clinical use of evidence-based medicine--clinical questions: Acetylcysteine, a new treatment for an old foe? [2006.09]
Treatment of proliferative lupus nephritis: a changing landscape. [2006.08]
Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation. [2006.07]
Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. [2006.05]
Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial. [2006.05]
Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships. [2006.04]
Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. [2006.03]
Advances in the therapy of Wegener's granulomatosis. [2006.01]
Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials. [2006]
High-dose acetylcysteine in idiopathic pulmonary fibrosis. [2005.11.24]
Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion. [2005.08]
A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation. [2005.06]
Everolimus alters the bronchoalveolar lavage and endobronchial biopsy immunologic profile post-human lung transplantation. [2005.06]
An open, randomized, multicenter clinical trial of oral tacrolimus in liver allograft transplantation: a comparison of dual vs. triple drug therapy. [2005.05]
Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies. [2005.05]
Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. [2005.04]
[Necessity and safety of conversion from mycophenolate mofetil to AzA thioprine after renal transplantation] [2005.03.16]
Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy. [2005.03]
Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy. [2005.02]
Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens. [2005.02]
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study. [2005.01.15]
[Assessment of early immunosuppressive therapy in the prevention of complications of Graves' disease] [2004]
Other research related to Imuran (Azathioprine)
Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. [2008.09.01]
Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris. [2008.09]
[Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease] [2008.09]
Sweet syndrome as a manifestation of azathioprine hypersensitivity. [2008.09]
Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data. [2008.08.08]
Comparative Analysis of Azathioprine versus Cyclosporine-based Therapy in Primary Haplo-identical Live-Donor Kidney Transplantation: A 20-Year Experience. [2008.07]
Azathioprine-induced warfarin resistance. [2008.07]
Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. [2008.07]
Paradoxical elevated thiopurine S-methyltransferase activity after pancytopenia during azathioprine therapy: potential influence of red blood cell age. [2008.06]
Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity. [2008.06]
Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn's disease? [2008.05.08]
[Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?] [2008.05]
[Epstein-Barr virus-associated large B-cell lymphoma in a patient with colitis ulcerosa treated with azathioprine] [2008.04.07]
The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse. [2008.04]
|
